The 1-year high price for the company’s stock is recorded $10.87 on 04/09/21, with the lowest value was $3.90 for the same time period, recorded on 03/05/21. GT Biopharma, Inc. was incorporated in 1965 and is … GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel immuno-oncology products based on its proprietary technology platforms. Find the latest GT Biopharma, Inc. (GTBP) stock quote, history, news and other vital information to help you with your stock trading and investing. Is GT Biopharma's dividend showing long-term growth? The company develops immuno-oncology product candidates, including GTB-1550, a bispecific scFv recombinant fusion protein-drug conjugate that targets cancer cells expressing the CD19 receptor or … View GT Biopharma's earnings history. ... History Related Operating Income-12.15M. GT Biopharma Inc. had a pretty favorable run when it comes to the market performance. Operating Margin-Total Equity-Retained Earnings-Free Cashflow-Price/Cashflow- … GT BIOPHARMA : Adds university of wisconsin-madison carbone cancer center as second site in ongoing phase 1/2 clinical trial of gtb-3550 trike, a novel nk cell therapeutic cancer treatment AQ Summary GT Biopharma (NASDAQ: GTBP) does not pay a dividend. GT Biopharma Inc. annual balance sheet for GTBP company financials. GT Biopharma … View today's stock price, news and analysis for GT Biopharma Inc. (GTBP). GT Biopharma, Inc. (OTCMKTS:GTBP) announced its quarterly earnings data on Thursday, April, 15th. GT Biopharma (NASDAQ: GTBP) does not pay a dividend. The company reported ($3.39) EPS for the quarter, missing the consensus estimate of ($0.04) by $3.35. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … GT Biopharma, Inc. Common Stock (GTBP) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. GT Biopharma Inc. NASDAQ: GTBP. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. US Markets closed. Historical performance for GT Biopharma Inc (GTBP) with historical highs & lows, new high & low prices, past performance, latest news.